{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:15:40Z","timestamp":1790846140370,"version":"4.1.0"},"reference-count":21,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.19812","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T11:32:46Z","timestamp":1628249566000},"page":"e2119812","source":"Crossref","is-referenced-by-count":25,"title":["Association of Thrombosis With Hypereosinophilic Syndrome in Patients With Genetic Alterations"],"prefix":"10.1001","volume":"4","author":[{"given":"Orly","family":"Leiva","sequence":"first","affiliation":[{"name":"Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olesya","family":"Baker","sequence":"additional","affiliation":[{"name":"Center for Clinical Investigation, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Brunner","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanny","family":"Al-Samkari","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Karp","family":"Leaf","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel P.","family":"Rosovsky","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir T.","family":"Fathi","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Weitzman","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Bornikova","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Nardi","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela S.","family":"Hobbs","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,8,6]]},"reference":[{"issue":"3","key":"zoi210589r1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/ajh.v89.3","article-title":"World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.","volume":"89","author":"Gotlib","year":"2014","journal-title":"Am J Hematol"},{"issue":"3","key":"zoi210589r2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4274\/Tjh","article-title":"A case of hypereosinophilic syndrome presenting with multiorgan thromboses associated with intestinal obstruction.","volume":"30","author":"Sui","year":"2013","journal-title":"Turk J Haematol"},{"issue":"4","key":"zoi210589r3","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1001\/archneurol.2009.36","article-title":"Cerebral arteriolar thromboembolism in idiopathic hypereosinophilic syndrome.","volume":"66","author":"Grigoryan","year":"2009","journal-title":"Arch Neurol"},{"issue":"4","key":"zoi210589r4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/bjh.2014.165.issue-4","article-title":"Catastrophic thrombosis in idiopathic hypereosinophilic syndrome.","volume":"165","author":"Todd","year":"2014","journal-title":"Br J Haematol"},{"key":"zoi210589r5","first-page":"213","article-title":"Acute pulmonary embolism and deep vein thrombosis secondary to idiopathic hypereosinophilic syndrome.","volume":"25","author":"Li","year":"2018","journal-title":"Respir Med Case Rep"},{"key":"zoi210589r6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.12.1105","article-title":"Hypereosinophilic syndrome and thrombosis: a retrospective review.","volume":"131","author":"Wallace","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"zoi210589r7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111862","article-title":"Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: a possible link with thrombosis.","volume":"9","author":"Cugno","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"zoi210589r8","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1182\/blood-2005-05-2152","article-title":"The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states.","volume":"107","author":"Wang","year":"2006","journal-title":"Blood"},{"issue":"4","key":"zoi210589r9","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1172\/JCI116382","article-title":"Eosinophil cationic granule proteins impair thrombomodulin function. a potential mechanism for thromboembolism in hypereosinophilic heart disease.","volume":"91","author":"Slungaard","year":"1993","journal-title":"J Clin Invest"},{"issue":"4","key":"zoi210589r10","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1084\/jem.172.4.1271","article-title":"Activation of platelets by eosinophil granule proteins.","volume":"172","author":"Rohrbach","year":"1990","journal-title":"J Exp Med"},{"issue":"20","key":"zoi210589r11","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"8","key":"zoi210589r12","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/modpathol.2016.75","article-title":"Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.","volume":"29","author":"Wang","year":"2016","journal-title":"Mod Pathol"},{"issue":"10","key":"zoi210589r13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185602","article-title":"Idiopathic hypereosinophilia is clonal disorder? clonality identified by targeted sequencing.","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"zoi210589r14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12885-019-5387-9","article-title":"A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms.","volume":"19","author":"Rungjirajittranon","year":"2019","journal-title":"BMC Cancer"},{"issue":"2","key":"zoi210589r15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease.","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi210589r16","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1182\/blood-2016-10-695973","article-title":"Myeloid neoplasms with eosinophilia.","volume":"129","author":"Reiter","year":"2017","journal-title":"Blood"},{"issue":"1","key":"zoi210589r17","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1182\/asheducation-2018.1.326","article-title":"Hypereosinophilic syndrome: approach to treatment in the era of precision medicine.","volume":"2018","author":"Klion","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"7","key":"zoi210589r18","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/jth.13336","article-title":"Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH.","volume":"14","author":"Kearon","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"7","key":"zoi210589r19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071958","article-title":"Impact of tumor genomic mutations on thrombotic risk in cancer patients.","volume":"12","author":"Leiva","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"2","key":"zoi210589r20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/bjh.v189.2","article-title":"Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera.","volume":"189","author":"Tefferi","year":"2020","journal-title":"Br J Haematol"},{"key":"zoi210589r21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.critrevonc.2018.07.013","article-title":"Prognostic value and clinical feature of SF3B1 mutations in myelodysplastic syndromes: a meta-analysis.","volume":"133","author":"Tang","year":"2019","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2782756\/leiva_2021_oi_210589_1627575036.40387.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T11:32:51Z","timestamp":1628249571000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2782756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,6]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.19812","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,6]]}}}